Park Ha Biological Technology Sets February 20 Effective Date for 1-for-50 Reverse Stock Split

Park Ha Biological Technology ( (BYAH) ) just unveiled an update.

Park Ha Biological Technology detailed changes to its capital structure tied to a previously announced 1‑for‑50 reverse stock split of its Class A and Class B ordinary shares, which was approved by shareholders on December 26, 2025 and by the board on January 29, 2026. Subject to Nasdaq operational requirements, the reverse split is expected to take effect on February 20, 2026, when trading in the company’s shares will begin on a split‑adjusted basis.

Immediately before the split, as of the date of the February 13, 2026 filing, the company had 104,768,362 ordinary shares outstanding, including 85,718,362 Class A and 19,050,000 Class B shares, a figure that incorporates its January 28, 2026 follow‑on offering and related warrant exercises. After the reverse split, outstanding share capital is expected to shrink to 2,095,368 ordinary shares—1,714,368 Class A and 381,000 Class B—with no fractional shares issued and any fractional positions rounded up, while the economic and voting terms of the securities otherwise remain unchanged, signaling a technical capital adjustment rather than a change in control or rights for existing holders.

More about Park Ha Biological Technology

Park Ha Biological Technology Co., Ltd., based in Wuxi, Jiangsu Province, China, is a foreign private issuer listed on Nasdaq and operates in the life sciences and biological technology sector. The company has a dual‑class share structure consisting of Class A ordinary shares with one vote per share and Class B ordinary shares carrying 20 votes per share, reflecting a governance model that concentrates voting power with key stakeholders.

Average Trading Volume: 12,729,289

Technical Sentiment Signal: Strong Sell

Current Market Cap: $2.43M

For an in-depth examination of BYAH stock, go to TipRanks’ Overview page.